Biosynthesis and regulation of secondary metabolites in microorganisms by unknown
SCIENCE CHINA 
Life Sciences 
© The Author(s) 2013. This article is published with open access at Springerlink.com life.scichina.com   www.springer.com/scp 
                  
*Corresponding author (email: tanhr@im.ac.cn) 
SPECIAL TOPIC: Biosynthesis and regulation of secondary metabolites in microorganisms July 2013  Vol.56  No.7: 581–583 
• EDITORIAL • doi: 10.1007/s11427-013-4501-5  
Progress of Projects Supported by NSFC 
Biosynthesis and regulation of secondary metabolites in 
microorganisms 
NIU GuoQing & TAN HuaRong* 
State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China 
Received May 29, 2013 
 





Secondary metabolites are organic compounds with com-
plex chemical structures and diverse physiological functions. 
Secondary metabolites include antibiotics, pigments, and 
other bioactive compounds. Many of these compounds have 
important agricultural and medical applications. Microor-
ganisms, especially actinomycetes and filamentous fungi, 
are noted as a rich source of bioactive secondary metabo-
lites. Typically, each species produces several antibiotics, 
with the profile being species-specific. 
Secondary metabolites are synthesized from their pre-
cursors through multistep biosynthetic pathways. In general, 
the genes governing the biosynthesis of secondary metabo-
lites are clustered together, and an increasing number of 
gene clusters responsible for the biosynthesis of secondary 
metabolites have been discovered. The availability of clus-
ters has accelerated functional investigations of biosynthetic 
pathways of secondary metabolites. A thorough under-
standing of the enzymatic process is required for metabolic 
engineering to improve production of secondary metabolites 
and for combinatorial biosynthesis to generate novel com-
pounds or derivatives. Elucidation of the biosynthetic pro-
cess requires knowledge from diverse disciplines, including 
bioinformatics, chemistry, and genetics. 
Secondary metabolites are generally produced during the 
stationary phase of growth in microorganisms. The biosyn-
thesis of secondary metabolites is a complex process in-
volving cascade regulations, and these regulatory mecha-
nisms have been investigated extensively at the transcrip-
tional level. However, regulation could also occur at the 
pre-transcriptional and/or post-transcriptional levels. Pre- 
transcriptional regulation occurs primarily at the chromatin 
level (epigenetic regulation), while post-transcriptional regu-
lation is achieved via small non-coding RNAs (sRNAs) and 
protein degradation machinery. Though still in its infancy, 
some interesting progress has been made in this field [1,2]. 
As antibiotics are the most important of the secondary 
metabolites, we will focus on antibiotics hereafter. The 
alarming rise in emergence and prevalence of antibiotic 
resistance poses a major threat to human healthcare. It is 
clear that novel antibiotics are urgently needed to combat 
this problem. However, the supply of new antibiotics has 
declined in the last decade [3]. To reverse this trend, several 
strategies have been devised to find or create new antibiot-
ics, which we describe in detail below. 
1  Generation of new derivatives 
Based on results from extensive biosynthetic studies, selec-
tive inactivation of structural genes can produce new antibi-
otic analogs [4,5]. Mutasynthesis can be started by blocking 
the biosynthesis of key biosynthetic components, and a va-
riety of alternative biosynthetic intermediates can then be 
fed to the mutant to produce novel antibiotic variants. Com-
binatorial biosynthesis takes advantage of similarities be-
tween the molecular structures of two or more antibiotics to 
generate hybrid compounds with improved properties [6].  
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2  Design of new antibiotics by synthetic biology 
By applying the engineering paradigm of systems design to 
biological systems, synthetic biology can generate unnatural 
compounds with predictable features. The successful appli-
cation of this technology requires a diverse library of bio-
logical modules. These modules can be integrated to assem-
ble complex pathways in a programmed fashion. The as-
sembled pathway needs a suitable surrogate host for pro-
duction, and Escherichia coli is the most commonly used 
[7]. Alternative hosts, like Streptomyces, have also been 
successful [8]. By using the well-developed hosts as a bio-
logical factory, we can produce new antibiotics through 
assembly of designed and compatible modules.  
3  Activation of cryptic gene clusters 
Advances in omics and bioinformatics have promoted the 
investigation of biosynthesis and regulation of secondary 
metabolites. Genome mining and scanning are frequently 
used to find new secondary metabolites. Sequencing of mi-
crobial genomes has revealed a large number of secondary 
metabolic gene clusters. However, most of these gene clus-
ters are expressed inefficiently, or not at all, under standard 
culture conditions. Therefore, it is necessary to develop new 
methods and strategies to identify the physiological signals 
and regulatory mechanisms responsible for the activation of 
these “cryptic” pathways. Activating these clusters will 
open up new avenues for identifying novel and important 
antibiotics. The discovery of natural products by ge-
nomic-based approaches largely depends on the identifica-
tion and annotation of secondary metabolite gene clusters 
through in silico analysis. Once these gene clusters are 
identified, various methods are needed for activating the 
expression of cryptic gene clusters. These methods include 
optimization of fermentation conditions, genome mining, 
ribosome engineering, genetic manipulation of the regula-
tors controlling gene clusters, induction of signaling mole-
cules, and heterologous expression of gene clusters in dif-
ferent host strains [9].  
4  Novel antibiotics from marine microorga- 
nisms 
Marine microorganisms exist in an environment that is very  
different from that of their terrestrial counterparts. They 
have to adapt to different conditions, and thus gain different 
metabolic capabilities. Marine microorganisms represent an 
untapped source from which novel antibiotics can be dis-
covered. Since the vast majority of these microorganisms 
remain unculturable in the laboratory, metagenome libraries 
from a large number of marine samples are needed to access 
the genetic material of these species. Considering the high 
diversity of this genetic material, there is a greater chance of 
finding novel antibiotics. 
This special issue is dedicated to the biosynthesis and 
regulation of secondary metabolites from microorganisms 
of terrestrial or marine origin. We would like to thank all 
authors for their contributions. We sincerely hope that this 
special topic will encourage scientists, especially young 
scientists, to work in this important field of novel antibiotic 
discovery, and to report their findings in future issues of 
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